Middle East Healthcare Company announces its intention to issue Sukuk denominated in Saudi Riyals by way of a public offering

16 January 2024

Introduction	Introduction With reference to the Capital Market Authority’s approval of the application submitted by the Middle East Healthcare Company (the “Company”) to register and offer Sukuk denominated in SAR (the "Sukuk") pursuant to the SAR denominated Sukuk issuance programme (the “Programme”) established by the Company on 02/07/1445H (corresponding to 14/01/2024G), the Company announces its intention to issue the Sukuk and the public offering thereof pursuant to the Programme. The Company has mandated Al Rajhi Capital Company as financial advisor, sole arranger and dealer for the purposes of establishing the Programme and the issuance and offering of the Sukuk thereunder.
Offer Type	Public offering of Sukuk denominated in Saudi Riyals.
Date of the board’s decision	2023-08-28 Corresponding to 1445-02-12.
Value of the offer	The issuance amount will be determined at a later stage based on market conditions at that time.
The Purpose of the offer	The Company will use the offering proceeds for its general corporate purposes.
Approvals	The Capital Market Authority has issued its approval on 20/05/1445H (corresponding to 04/12/2023G) on the Company’s application to register and offer the Sukuk pursuant to the Programme. The Saudi Exchange Company (Tadawul) has issued its approval on 11/04/1445H (corresponding to 26/10/2023G) on the Company’s application to list the Sukuk on the Saudi Stock Exchange (Tadawul).
Additional Information	The base prospectus in relation to the Sukuk has been published and can be viewed on the Capital Market Authority’s website (https://cma.org.sa), the website of the Saudi Stock Exchange (Tadawul) (www.saudiexchange.sa) and the website of the financial adviser, sole arranger and dealer (https://www.alrajhi-capital.com). The base prospectus can be viewed at the following link: Click Here The Company emphasises the importance of thoroughly and completely reviewing the base prospectus before deciding to invest in any offering of the Sukuk. This announcement is not intended as an invitation or offer to purchase, acquire or subscribe to any securities. The Company will announce any other relevant material developments in due course as required by the relevant rules and regulations. Prior to the commencement of the offering period, the Company intends to conduct roadshows in relation to the Sukuk to specific categories of investors to gauge interest in the offer and market demand.